(5E)-5-(2,5-dimethoxybenzylidene)-2-mercapto-1,3-thiazol-4(5H)-one, 95.0%, 1g

1-(3-Nitropyridin-2-yl)-1,4-diazepane, 95.0%, 1g

DL-arginine, min 98,5 %, pour la biochimie, 5 g, emballage plastique.

(R)-5-(tert-Butoxy)-3-((tert-butoxycarbonyl)amino)-5-oxopentanoic acid, 98%, 250mg

2-Fluoro-3-hydroxybenzonitrile, 95.0%, 1g

2-Chlorophénol, ≥98 %, pour la synthèse, 2,5 L, emballage verre

1,5-Cyclooctadiene [stabilized with Octadecyl 3-(3',5'-Di-tert-butyl-4'-hydroxyphenyl)propionate]>98.0%(GC)100mL

(4-Bromo-3-methylphenyl)boronic acid, 95.0%, 1g

3-Oxocyclobutyl benzoate, 95.0%, 10g

1-Bromo-4-phenylnaphthalene>98.0%(GC)5g

4-Methyl-2-(trifluoromethyl)benzoic acid, 98.0%, 5g

Cartouche échangeuse d'ions série DS, DS 1500, 1 Pièce(s)

(2E)-1-(2,4-dimethylphenyl)-3-(furan-2-yl)prop-2-en-1-one, 95.0%, 2g